OBJECTIVES: To determine the levels of resistance to first-line tuberculosis drugs in three cities in three geopolitical zones in Nigeria. METHODS: A total of 527 smear-positive sputum samples from Abuja, Ibadan and Nnewi were cultured on BACTEC- MGIT 960. Drug susceptibility tests (DST) for streptomycin, isoniazid, rifampicin and ethambutol were performed on 428 culture-positive samples on BACTEC-MGIT960. RESULTS: Eight per cent of the specimens cultured were multi-drug-resistant Mycobacterium tuberculosis (MDR-TB) with varying levels of resistance to individual and multiple first-line drugs. MDR was strongly associated with previous treatment: 5% of new and 19% of previously treated patients had MDR-TB (OR 4.1 (95% CI 1.9-8.8), P = 0.001) and with young adult age: 63% of patients with and 38% without MDR-TB were 25-34 years old (P = 0.01). HIV status was documented in 71%. There was no association between MDR-TB and HIV coinfection (P = 0.9) and gender (P > 0.2 for both). CONCLUSIONS: MDR-TB is an emerging problem in Nigeria. Developing good quality drug susceptibility test facilities, routine monitoring of drug susceptibility and improved health systems for the delivery of and adherence to first- and second-line treatment are imperative to solve this problem.
OBJECTIVES: To determine the levels of resistance to first-line tuberculosis drugs in three cities in three geopolitical zones in Nigeria. METHODS: A total of 527 smear-positive sputum samples from Abuja, Ibadan and Nnewi were cultured on BACTEC- MGIT 960. Drug susceptibility tests (DST) for streptomycin, isoniazid, rifampicin and ethambutol were performed on 428 culture-positive samples on BACTEC-MGIT960. RESULTS: Eight per cent of the specimens cultured were multi-drug-resistant Mycobacterium tuberculosis (MDR-TB) with varying levels of resistance to individual and multiple first-line drugs. MDR was strongly associated with previous treatment: 5% of new and 19% of previously treated patients had MDR-TB (OR 4.1 (95% CI 1.9-8.8), P = 0.001) and with young adult age: 63% of patients with and 38% without MDR-TB were 25-34 years old (P = 0.01). HIV status was documented in 71%. There was no association between MDR-TB and HIV coinfection (P = 0.9) and gender (P > 0.2 for both). CONCLUSIONS: MDR-TB is an emerging problem in Nigeria. Developing good quality drug susceptibility test facilities, routine monitoring of drug susceptibility and improved health systems for the delivery of and adherence to first- and second-line treatment are imperative to solve this problem.
Authors: Sarwat Chowdhury; Kelly N Owens; R Jason Herr; Qin Jiang; Xinchao Chen; Graham Johnson; Vincent E Groppi; David W Raible; Edwin W Rubel; Julian A Simon Journal: J Med Chem Date: 2017-10-27 Impact factor: 7.446
Authors: Lovett Lawson; Jian Zhang; Michel K Gomgnimbou; Saddiq T Abdurrahman; Stéphanie Le Moullec; Fatima Mohamed; Gertrude N Uzoewulu; Olumide M Sogaolu; Khye Seng Goh; Nnamdi Emenyonu; Guislaine Refrégier; Luis E Cuevas; Christophe Sola Journal: PLoS One Date: 2012-06-18 Impact factor: 3.240
Authors: Florian Gehre; Jacob Otu; Lindsay Kendall; Audrey Forson; Awewura Kwara; Samuel Kudzawu; Aderemi O Kehinde; Oludele Adebiyi; Kayode Salako; Ignatius Baldeh; Aisha Jallow; Mamadou Jallow; Anoumou Dagnra; Kodjo Dissé; Essosimna A Kadanga; Emmanuel Oni Idigbe; Catherine Onubogu; Nneka Onyejepu; Aissatou Gaye-Diallo; Awa Ba-Diallo; Paulo Rabna; Morto Mane; Moumine Sanogo; Bassirou Diarra; Zingue Dezemon; Adama Sanou; Madikay Senghore; Brenda A Kwambana-Adams; Edward Demba; Tutty Faal-Jawara; Samrat Kumar; Leopold D Tientcheu; Adama Jallow; Samba Ceesay; Ifedayo Adetifa; Assan Jaye; Mark J Pallen; Umberto D'Alessandro; Beate Kampmann; Richard A Adegbola; Souleymane Mboup; Tumani Corrah; Bouke C de Jong; Martin Antonio Journal: BMC Med Date: 2016-11-03 Impact factor: 8.775
Authors: Barbara Molina-Moya; Michel K Gomgnimbou; Lizania Spinasse; Joshua Obasanya; Olanrewaju Oladimeji; Russell Dacombe; Thomas Edwards; Xavier-Olessa Daragon; Lovett Lawson; Saddiq T Abdurrahman; Luis E Cuevas; Jose Dominguez; Christophe Sola Journal: PLoS Negl Trop Dis Date: 2018-02-15
Authors: Lovett Lawson; Nanmdi Emenyonu; Saddiq T Abdurrahman; Juliana O Lawson; Gertrude N Uzoewulu; Olumide M Sogaolu; Juliana N Ebisike; Christopher M Parry; Mohammed A Yassin; Luis E Cuevas Journal: BMC Res Notes Date: 2013-05-30